1 / 10

With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science

Pinnacle Life Science is a 100% subsidiary of Indiau2019s most trusted pharmaceutical company Aarti Drugs Ltd (ADL) and forms part of $ 1.5 billion conglomerate of the esteemed Aarti Group of Industries.

pinnaclelifescience
Download Presentation

With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science

  2. About Pinnacle Lifescience • Pinnacle Life Science is a 100% subsidiary of India’s most trusted pharmaceutical company Aarti Drugs Ltd (ADL) and forms part of $ 1.5 billion conglomerate of the esteemed Aarti Group of Industries. • With 35 years of healthcare commitment through Aarti Drugs, Pinnacle has made its presence in nearly 90+ countries. Treading carefully on the path of efficient healthcare, the state-of-the-art manufacturing facility is designed to produce formulations that meet international quality standards and stringent regulatory compliances to trade beyond borders. • With significant expansion in R&D, Manufacturing & Marketing capabilities, we are poised for an accelerated growth.

  3. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • Medicine has seen a new future with technological advancement. It has become inevitable to detect and diagnose a medical condition without involving medical technology. Oncology is one such department that has evolved significantly after the discovery of precision medicine. • The top oncology pharma companies in India use precision medicine as a branch of science that caters to medical requirements based on individual health conditions, lifestyles, and environments for every patient. Precision medicine is far more beneficial for treating a chronic illness as it meets individual needs. No one would have thought that a day might come when medicine would cater to independent medical conditions.

  4. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • However, all the data derived depends on studying the patient’s genes. Again it is not an easy task to take out extra time for every medical condition, especially cancer. Analysing and understanding individual genes helps to plan out the patient’s treatment in a more personalised manner. But one question that lingers now and then is how to ensure that the data derived from the interpretation tools are accurate. Every significant oncology pharma company in India ensures that its interpretation is based on specific elements. It makes the data collected more credible. • There are certain elements that every interpretation tool has for a better understanding of oncology precision medicine.

  5. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • Comprehensive Data • Precision medicine relates to equating the patient to the treatment. As a result, it is essential to have broad information on the type of cancer, its origin, treatment plan, and prognosis. Cancer has a blanket of categories, from HER-2-positive breast cancer to tumours. Search a knowledge base covering hundreds of genes known to be associated with cancer, including thousands of clinically relevant variants. Molecular content should represent the entire scientific literature and ideally be presented to the user at the gene and variant level, capturing complex molecular profiles. In addition to molecular data, solid knowledge of cancer includes targeted therapy in different countries, clinical trials with specific molecules and other inclusive criteria, and proof-of-concept of available treatments are some ways oncology pharma companies in India ensure proper data extraction.

  6. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • Maintenance and curation • Numerous cancer knowledge bases started at the best hours of research but, after collecting the initial data, got neglected from research. In the world of oncology, knowledge bases can quickly become obsolete. Look for tools that are updated regularly (preferably daily) for the latest scientific knowledge, clinical data, professional guidelines, and drug approvals. Also, top oncology pharma companies in India try to prioritise expert curation whenever possible. Scientific or clinical experts should perform the curation process with the necessary skills and training to review new content and ensure it applies to the knowledge base. Finally, look for a knowledge base that consistently organises and structures your data. Some of the oncology pharma companies in India also use data mapping.

  7. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • Ease of use • One aspect that escapes the knowledge of everyone is the ease of use. Every top oncology pharma company in India focuses on using research and development tools that are simple to use. But tools that are too difficult or unwieldy do not help researchers and clinicians. Make sure the knowledge base you consider is user-friendly. For example, the search functionality should be sophisticated enough to return all relevant results yet still be intuitive to the user.

  8. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • Bottom line • A oncology research and development centre that meets all these criteria can uncover clinically relevant and detailed insights that are virtually impossible to find otherwise. In one study, scientists used a comprehensive cancer knowledge base to assess ALK fusion profiles and decide on treatment efficacy. They found that two separate ALK fusions responded differently to the same ALK inhibitor. Both have the same secondary resistance mutation. An interpretation using extensive analytical resources allows scientists belonging to the oncology pharma companies in India to find evidence that one molecular profile is associated with drug susceptibility.

  9. With More Oncology Data At Our Fingertips, Interpretation Tools Are Key - Pinnacle Life Science • These closely related but functionally distinct molecular profiles will become more prevalent in oncology research as our ability to collect and recognise data improves. To understand and ultimately tailor treatment as carefully as possible, the approach towards oncology must be a data-driven field. Hence, to bring the potential of precision medicine to the bedside of cancer patients, interpretive tools must be robust, reliable, comprehensive, and easily accessible.

  10. Contact Us Address: Mahendra Industrial Estate, Ground Floor, Plot No. 109D, Road No 29, Sion(E) Mumbai-400022, India. Phone No: +91 (22) – 24019025 Email: export.pinnacle@aartidrugs.com Site: www.pinnaclelifescience.com

More Related